510(k) K092223

MODIFICATION TO: BINAXNOW INFLUENZA A & B TEST by Binax, Inc. — Product Code PSZ

K092223 is an FDA 510(k) premarket notification submitted by Binax, Inc. for the device "MODIFICATION TO: BINAXNOW INFLUENZA A & B TEST". The FDA issued a decision of Substantially Equivalent on Aug 12, 2009. The device falls under product code PSZ (Devices Detecting Influenza A, B, And C Virus Antigens), a Class II device regulated under 21 CFR 866.3328. Binax, Inc. has 29 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 12, 2009
Date Received
Jul 23, 2009
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Devices Detecting Influenza A, B, And C Virus Antigens
Device Class
Class II
Regulation Number
866.3328
Review Panel
MI
Submission Type
510(k)

An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.

Need the full FDA record for Binax, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K092223. Report a data issue: hello@regdatalab.com.